Immune Modulation Therapy for Pompe Disease

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
The purpose of this study is to assess anti-recombinant human acid α-glucosidase (anti-rhGAA) antibody titers after treatment with immune modulation therapy in patients of Pompe disease.
Epistemonikos ID: 2b5244f3bb1bffd13d59a863950539c5ad1e0c74
First added on: May 12, 2024